Iminopyrimidinones: A novel pharmacophore for the development of orally active renin inhibitors
- 1 April 2015
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (7) , 1592-1596
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Structure-Based Design of Substituted Piperidines as a New Class of Highly Efficacious Oral Direct Renin InhibitorsACS Medicinal Chemistry Letters, 2014
- Lead optimization of 5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxyhexanamides to reduce a cardiac safety issue: Discovery of DS-8108b, an orally active renin inhibitorBioorganic & Medicinal Chemistry, 2013
- Recent progress on the discovery of non-peptidic direct renin inhibitors for the clinical management of hypertensionExpert Opinion on Drug Discovery, 2013
- Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical UtilityACS Medicinal Chemistry Letters, 2011
- Renin inhibitors for the treatment of hypertension: Design and optimization of a novel series of pyridone-substituted piperidinesBioorganic & Medicinal Chemistry Letters, 2011
- Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I—Inhibitor Design and ValidationJournal of Medicinal Chemistry, 2009
- Chapter 5 Case History on Tekturna®/Rasilez® (Aliskiren), a Highly Efficacious Direct Oral Renin Inhibitor as a New Therapy for Hypertension2009
- Clinical Pharmacokinetics and Pharmacodynamics of AliskirenClinical Pharmacokinetics, 2008
- Novel therapies blocking the renin–angiotensin–aldosterone system in the management of hypertension and related disordersJournal Of Hypertension, 2007
- Ligand efficiency: a useful metric for lead selectionDrug Discovery Today, 2004